The experiences of pregnancy in women with SSA/Ro52 autoantibodies

Musculoskeletal Care

Volumn 8, Issue 4, 2010, Pages 215-223

  Tingström, Joanna ^a   Barimani, Mia ^a   Sonesson, Sven Erik ^a   Wahren Herlenius, Marie ^a   Henriksson, Elisabet Welin ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Congenital heart block; Doppler echocardiography; Pregnancy; Semi structured interview

Indexed keywords

ANTINUCLEAR ANTIBODY; RIBONUCLEOPROTEIN; SS A ANTIBODIES; SS A ANTIGEN; SS-A ANTIBODIES; SS-A ANTIGEN;

ADULT; ARTICLE; BLOOD; DOCTOR PATIENT RELATION; ECHOGRAPHY; FEMALE; FETOMATERNAL TRANSFUSION; FETUS ECHOGRAPHY; HEART BLOCK; HUMAN; IMMUNOLOGY; INFORMATION PROCESSING; MATERNAL BEHAVIOR; MENTAL STRESS; METHODOLOGY; PREGNANCY; PREGNANCY COMPLICATION; PREGNANCY OUTCOME; PSYCHOLOGICAL ASPECT; RISK; SOCIAL SUPPORT; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; ANTIBODIES, ANTINUCLEAR; DATA COLLECTION; FEMALE; HEART BLOCK; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MATERNAL BEHAVIOR; MATERNAL-FETAL EXCHANGE; PHYSICIAN-PATIENT RELATIONS; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; RIBONUCLEOPROTEINS; RISK; SOCIAL SUPPORT; STRESS, PSYCHOLOGICAL; ULTRASONOGRAPHY, PRENATAL;

EID: 78649473911     PISSN: 14782189     EISSN: 15570681     Source Type: Journal    
DOI: 10.1002/msc.189     Document Type: Article

References (21)

1. Berg M, Honkasalo ML (2000). Pregnancy and diabetes - A hermeneutic phenomenological study of women's experiences. Journal of Psychosomatic Obstetrics and Gynaecology 21: 39-48.
2. Bergman G, Eliasson H, Bremme K, Wahren-Herlenius M, Sonesson SE (2009). Anti-Ro52/SSA antibody-exposed fetuses with prolonged atrioventricular time intervals show signs of decreased cardiac performance. Ultrasound in Obstetrics and Gynecology 34: 543-549.
3. Bergman G, Jacobsson LA, Wahren-Herlenius M, Sonesson SE (2006). Doppler echocardiographic and electrocardiographic atrioventricular time intervals in newborn infants: Evaluation of techniques for surveillance of fetuses at risk for congenital heart block. Ultrasound in Obstetrics and Gynecology 28: 57-62.
4. Brucato A, Frassi M, Franceschini F, Cimaz R, Faden D, Pisoni MP, Muscara M, Vignati G, Stramba-Badiale M, Catelli L, Lojacono A, Cavazzana I, Ghirardello A, Vescovi F, Gambari PF, Doria A, Meroni PL, Tincani A (2001). Risk of congenital complete heart block in newborns of mothers with anti-Ro/SSA antibodies detected by counterimmunoelectrophoresis: A prospective study of 100 women. Arthritis and Rheumatism 44: 1832-1835.
5. Buyon JP (1994). Neonatal lupus syndromes. Current Opinion in Rheumatology 6: 523-529.
6. Carolan M, Hodnett E (2009). Discovery of soft markers on fetal ultrasound: Maternal implications. Midwifery 25: 654-664.
7. Cox MJ (1985). Progress and continued challenges in understanding the transition to parenthood. Journal of Family Issues 6: 395-408.
8. Elo S, Kyngas H (2008). The qualitative content analysis process. Journal of Advanced Nursing 62: 107-115.
9. Graneheim UH, Lundman B (2004). Qualitative content analysis in nursing research: Concepts, procedures and measures to achieve trustworthiness. Nurse Education Today 24: 105-112.
10. Haga HJ, Gjesdal CG, Irgens LM, Ostensen M (2005). Reproduction and gynaecological manifestations in women with primary Sjogren's syndrome: A case-control study. Scandinavian Journal of Rheumatology 34: 45-48.
11. Julkunen H, Kaaja R, Kurki P, Palosuo T, Friman C (1995). Fetal outcome in women with primary Sjogren's syndrome. A retrospective case-control study. Clinical and Experimental Rheumatology 13: 65-71.
12. Leithner K, Maar A, Fischer-Kern M, Hilger E, Loffler-Stastka H, Ponocny-Seliger E (2004). Affective state of women following a prenatal diagnosis: Predictors of a negative psychological outcome. Ultrasound in Obstetrics and Gynecology 23: 240-246.
13. McCain GC, Deatrick JA (1994). The experience of high-risk pregnancy. Journal of Obstetric, Gynecologic, and Neonatal Nursing 23: 421-427.
14. Neri F, Chimini L, Filippini E, Motta M, Faden D, Tincani A (2004). Pregnancy in patients with rheumatic diseases: Psychological implication of a chronic disease and neuropsychological evaluation of the children. Lupus 13: 666-668.
15. Skog A, Wahren-Herlenius M, Sundstrom B, Bremme K, Sonesson SE (2008). Outcome and growth of infants fetally exposed to heart block-associated maternal anti-Ro52/SSA autoantibodies. Pediatrics 121: e803-e809.
16. Skomsvoll JF, Ostensen M, Irgens LM, Baste V (1999). Perinatal outcome in pregnancies of women with connective tissue disease and inflammatory rheumatic disease in Norway. Scandinavian Journal of Rheumatology 28: 352-356.
17. Sonesson SE, Salomonsson S, Jacobsson LA, Bremme K, Wahren-Herlenius M (2004). Signs of first-degree heart block occur in one-third of fetuses of pregnant women with anti-SSA/Ro 52-kd antibodies. Arthritis and Rheumatism 50: 1253-1261.
18. Thorne S, Kirkham SR, MacDonald-Emes J (1997). Interpretive description: A noncategorical qualitative alternative for developing nursing knowledge. Research in Nursing and Health 20:169-177.
19. Thorne S (2008). Interpretive Description (Vol. 2). Walnut Creek, CA: Left Coast Press.
20. Wahren-Herlenius M, Sonesson SE (2006). Specificity and effector mechanisms of autoantibodies in congenital heart block. Current Opinion in Immunology 18: 690-696.
21. Waltuck J, Buyon JP (1994). Autoantibody-associated congenital heart block: Outcome in mothers and children. Annals of Internal Medicine 120: 544-551.